Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.90
-0.55 (-2.25%)
Mar 4, 2026, 1:52 PM CST
Market Cap1.77B +25.1%
Revenue (ttm)607.89M +30.6%
Net Income-83.60M
EPS-1.15
Shares Out72.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume125,409
Average Volume221,425
Open24.45
Previous Close24.45
Day's Range23.15 - 24.50
52-Week Range14.30 - 30.00
Beta0.12
RSI44.08
Earnings DateApr 24, 2026

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2024, Genomics BioSci & Tech.'s revenue was 482.75 million, an increase of 21.86% compared to the previous year's 396.14 million. Losses were -223.10 million, 32.7% more than in 2023.

Financial Statements